Align Technology, Inc. (NASDAQ:ALGN) Director Greg J. Santora Sells 7,700 Shares

Align Technology, Inc. (NASDAQ:ALGN) Director Greg J. Santora sold 7,700 shares of the company’s stock in a transaction dated Tuesday, October 31st. The shares were sold at an average price of $238.95, for a total value of $1,839,915.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Shares of Align Technology, Inc. (ALGN) opened at $249.46 on Monday. Align Technology, Inc. has a fifty-two week low of $88.56 and a fifty-two week high of $254.19. The company has a market capitalization of $20,000.00, a P/E ratio of 73.81, a P/E/G ratio of 2.39 and a beta of 1.41.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings results on Thursday, October 26th. The medical equipment provider reported $1.01 EPS for the quarter, beating the consensus estimate of $0.82 by $0.19. The firm had revenue of $385.30 million during the quarter, compared to analysts’ expectations of $359.80 million. Align Technology had a return on equity of 25.60% and a net margin of 19.98%. The business’s revenue for the quarter was up 38.3% on a year-over-year basis. During the same quarter last year, the firm earned $0.63 earnings per share. research analysts predict that Align Technology, Inc. will post 3.62 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This story was originally posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this story on another domain, it was stolen and republished in violation of US and international trademark and copyright law. The original version of this story can be accessed at https://ledgergazette.com/2017/11/13/align-technology-inc-algn-director-sells-1839915-00-in-stock.html.

A number of hedge funds have recently bought and sold shares of the business. Honkamp Krueger Financial Services Inc. increased its stake in Align Technology by 1.7% during the second quarter. Honkamp Krueger Financial Services Inc. now owns 2,037 shares of the medical equipment provider’s stock worth $306,000 after acquiring an additional 34 shares during the last quarter. Buckingham Asset Management LLC boosted its position in shares of Align Technology by 3.3% during the second quarter. Buckingham Asset Management LLC now owns 1,861 shares of the medical equipment provider’s stock worth $279,000 after buying an additional 59 shares during the period. Security Asset Management boosted its position in shares of Align Technology by 0.5% during the second quarter. Security Asset Management now owns 12,735 shares of the medical equipment provider’s stock worth $1,912,000 after buying an additional 65 shares during the period. BB&T Securities LLC boosted its position in shares of Align Technology by 3.5% during the second quarter. BB&T Securities LLC now owns 2,757 shares of the medical equipment provider’s stock worth $413,000 after buying an additional 94 shares during the period. Finally, Wrapmanager Inc. boosted its position in shares of Align Technology by 2.6% during the second quarter. Wrapmanager Inc. now owns 3,835 shares of the medical equipment provider’s stock worth $576,000 after buying an additional 99 shares during the period. 80.86% of the stock is owned by institutional investors.

Several research analysts recently issued reports on the company. Credit Suisse Group reaffirmed a “positive” rating and set a $261.00 target price (up from $209.00) on shares of Align Technology in a research report on Thursday. Zacks Investment Research upgraded Align Technology from a “hold” rating to a “buy” rating and set a $227.00 price target on the stock in a research note on Monday, October 30th. Leerink Swann reiterated an “outperform” rating and set a $250.00 price target on shares of Align Technology in a research note on Friday, October 27th. Robert W. Baird reiterated a “buy” rating and set a $245.00 price target on shares of Align Technology in a research note on Friday, October 27th. Finally, Stifel Nicolaus upped their target price on Align Technology from $205.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, October 23rd. Eleven equities research analysts have rated the stock with a buy rating, The stock has an average rating of “Buy” and a consensus target price of $219.18.

About Align Technology

Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.

Insider Buying and Selling by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply